EUCTR2008-002077-12-IT
Active, not recruiting
Not Applicable
?Fenoldopam end Renal failure? (FENO-HSR)
ConditionsRenal failure from ipoperfusion post Cardiac surgeryMedDRA version: 14.1Level: LLTClassification code 10000821Term: Acute kidney failureSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 14.1Level: PTClassification code 10048988Term: Renal artery occlusionSystem Organ Class: 10038359 - Renal and urinary disordersMedDRA version: 14.1Level: PTClassification code 10002482Term: AngiosclerosisSystem Organ Class: 10047065 - Vascular disordersTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Renal failure from ipoperfusion post Cardiac surgery
- Sponsor
- AZIENDA OSPEDALIERA DI PERUGIA
- Status
- Active, not recruiting
- Last Updated
- 12 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Sick undergo intervention cardiochirurgico who develop at any time during the postoperative hospital in Intensive Care, a screzio renal defined as ''R'' of the score of RIFLE (increase in creatinine of 50% compared to preoperatorio cardiochirurgico diuresis or with a less than 0 , 5 ml / kg / h for 6 hours) and a planned hospital in cardiac intensive care exceeding 24 hours). The upside of creatinine can happen at any time of hospitalization in Intensive Care (not necessarily in the first 24\-48 hours) for any reason (low flow, sepsis ..).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •\-\- Glaucoma \-\- Provided by the hospital intensive care within 24 hours \-\- Already taken the decision to place renal replacement treatment \-\- Already taken the decision not to therapeutic likely exitus \-\- Inclusion in other protocols randomized \-\- Age \<18 years \-\- Lack of informed consent \-\- Patients who received fenoldopam in the previous 30 days \-\- Preoperative dialysis (temporary or permanent)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Fenoldopam and renal insufficiency - NDpatients undergoing heart surgery developing, in any moment during post surgery hospitalization in Intensive Care Unit, renal problems named as R of RIFLE scoreMedDRA version: 9.1Level: SOCClassification code 10038359Term: Renal and urinary disordersEUCTR2007-003045-33-ITOSPEDALE S. RAFFAELE
Terminated
Not Applicable
The Effect of Fenoldopam in Solitary Partial Nephrectomy SurgeryPartial NephrectomyNCT00743106The Cleveland Clinic90
Terminated
Phase 2
Fenoldopam to Prevent Renal Dysfunction in Indomethacin Treated Preterm InfantsPatent Ductus Arteriosus (PDA)Acute Kidney Injury (AKI)NCT02620761Medical College of Wisconsin1
Completed
Phase 3
Fenoldopam and Acute Renal FailureAcute Renal FailureNCT00621790Università Vita-Salute San Raffaele667
Completed
Phase 2
A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac SurgeryCardiac Surgery With Cardiopulmonary BypassNCT00467181Summa Health System30